Arthneeti

Fortis Healthcare Q1 FY27 Share Price & Earnings Call Analysis

₹768.15+1.76% today
Market cap
₹57,992 Cr
P/E
54.36
ROE
11.23%
PEG
2.04
Price to sales
6.08
Debt to equity
0.35
52W high / low
₹1,045 / ₹713
Sales growth (5Y)
17.76%
EBITDA margin
22.42%
Net profit margin
11.83%
Promoter holding
31.17%
Sales (last year)
₹9,506 Cr

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1]

Guidance scorecard · Q1 FY27 call

What Fortis Health.'s management guided
and where it ranks in Healthcare Services

#32of 33 in
Healthcare Services
Revenue10–20%MarginsWhat management saidCapexPlannedFundraisingPlannedOrder bookWhat management said

RevenueQ1 FY27 call

10–20%
  • Fortis Healthcare remains fully committed to its growth plans and views Fortis as the growth engine for IHH's India platform.
  • IHH Healthcare has the ability and willingness to invest additional capital as needed for Fortis' expansion, including brownfield projects and M&A opportunities.
  • Operationally, Fortis has built a resilient and fully operational leadership team insulated from ongoing legal proceedings, ensuring steady execution.
  • Competitive intensity in the healthcare sector is increasing; Fortis plans to step up efforts to maintain and grow its market position.

2 more points from Fortis Health.'s call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

See what Fortis Health. said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • IHH remains fully committed to Fortis Healthcare and its growth plans.
  • There is no change in commitment to invest capital as needed for Fortis' expansion.
  • IHH can infuse more capital within legal limits over the next 6 to 12 months and beyond.
  • Growth plans including brownfield expansion and M&A activities will continue actively.
  • IHH has no impediments to investing in Fortis and supporting its growth engine in India.
  • The recent legal and forensic audit developments do not restrict corporate actions or capital infusion by IHH.

2 more points from Fortis Health.'s call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

Planned

See what Fortis Health. said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

Ask what Fortis Health. said on the order book →

Full Q1 FY27 analysis
Full Healthcare Services ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Services
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Aster DM Quality Care LtdGood growth
    3
See all potential multibaggersWhere does Fortis Health. rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Healthcare Services companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹903 Cr—
240%+Flat₹583 Cr22.2
3Aster DM Quality Care Ltd20–40%Up 2%+₹58,782 Cr162.9
420–40%Up 0–2%₹1,730 Cr17.5
520–40%Up 0–2%₹580 Cr11.9
620–40%Flat₹1.13L Cr53.9

Sign up free to see every company in the sector ranking and track Fortis Health..

Pro shows every company guiding 40%+ revenue growth →Full Healthcare Services ranking

Financials of Fortis Health.

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Fortis Health.

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +1,6431,6571,7701,6801,7861,8591,9881,9282,0072,1672,3312,2652,365
Expenses +1,3721,3861,4401,3961,4051,5161,5541,5531,5721,6761,7751,7591,832
Operating Profit271272330284381343435375435491556506532
OPM %16%16%19%17%21%18%22%19%22%23%24%22%23%
Other Income +261018191714-4247-293150-34-2
Interest32313233353536456870758684
Depreciation8279848792919597102101106120122
Profit before tax183171233183271230261279237351425266324
Tax %25%27%21%27%25%24%26%9%21%24%23%26%16%
Net Profit +138124184134203174193254188267329197271
EPS in Rs1.761.482.301.782.372.202.343.282.443.454.262.573.52

Financials of Fortis Health.

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +3,9664,1994,5744,5614,4694,6324,0305,7186,2986,8937,7839,128
Expenses +3,8574,1064,2204,2874,2384,0223,6264,6495,1965,6256,1957,043
Operating Profit109923542742316104041,0691,1011,2681,5882,085
OPM %3%2%8%6%5%13%10%19%17%18%20%23%
Other Income +92299649-6892281269536715764-1145
Interest152133229258337205166147129131184314
Depreciation235225222239233292291301316342386449
Profit before tax-18534552-912-110239439888148581,0071,366
Tax %2%-24%13%2%103%62%230%20%22%25%20%22%
Net Profit +-13042479-934-22491-567906336458091,064
EPS in Rs-3.100.408.14-19.46-3.960.77-1.457.357.807.9310.2613.80
Dividend Payout %-1%0%0%0%0%0%0%0%13%13%10%7%

Financials of Fortis Health.

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital463463518519755755755755755755755755
Reserves3,5853,9984,6263,5435,8465,9065,3655,4236,4876,9088,1629,141
Borrowings +1,7841,5132,2171,9622,0101,5941,5311,2559261,1552,4753,473
Other Liabilities +1,7601,2572,2272,4552,8752,7813,2164,0823,9214,1531,9852,598
Total Liabilities7,5927,2329,5888,47911,48611,03610,86611,51612,08912,97113,37715,966
Fixed Assets +4,2183,6425,4194,9928,4778,8028,7999,4169,4269,87410,42412,232
CWIP228226268226450204165193228542407432
Investments1,4641,4521,8781,732270175186104210230169243
Other Assets +1,6821,9132,0231,5292,2901,8561,7161,8032,2252,3262,3783,059
Total Assets7,5927,2329,5888,47911,48611,03610,86611,51612,08912,97113,37715,966

Financials of Fortis Health.

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +24195966493-1791724858658221,1001,4241,601
Cash from Investing Activity +213122-1,001-333-3,27963-131-501-372-889-780-1,538
Cash from Financing Activity +-304-354259-6724,257-862-143-517-471-86-714164
Net Cash Flow-66-37225-513799-627212-153-21125-70227
Free Cash Flow-181-162689437-26135274750367172591673
CFO/OP131%354%304%187%30%84%108%101%100%104%97%90%

Financials of Fortis Health.

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days383938384436413334333742
Inventory Days252323242230293331242324
Days Payable207218215279296226205178179164161165
Cash Conversion Cycle-144-156-155-217-230-161-135-112-115-107-101-99
Working Capital Days-71-69-87-113-234-150-56-35-22-124-30-34
ROCE %-0%3%11%3%6%4%2%10%10%10%12%13%

Guidance history

How Fortis Health.'s guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →10–20%—PlannedPlanned—
Q1 FY27 call →10–20%FlatPlanned——
Q3 FY26 call →10–20%Up 0–2%PlannedPlanned—

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

14out of 100

Momentum score · price trend

14 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−26.5%30%
Last 6 months−16.8%27%
Last 3 months−18.7%25%

The price is 30% below its all-time high of ₹1,097.9 (21 Oct 2025). Stocks more than 20% below their peak have their score halved, so 28 became 14.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Fortis Health.: 0.4 × 30 + 0.4 × 27 + 0.2 × 25 = 28, halved to 14 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Fortis Health.'s management said in earlier quarters

Others in Healthcare Services this season

  • Rainbow Childrens Medicare Ltd (Q2 FY27)

    Year-on-year (YoY) growth in revenue: 23.2% . Key investor presentation takeaways from Rainbow Childrens Medicare Ltd's Q2 FY27 investor presentation — and how

  • Narayana Hrudayalaya Ltd (Q2 FY27)

    Consolidated operating revenue for Q2 FY27: ₹28,440 Mn, up 73.0% YoY (Page 15, 16). Key investor presentation takeaways from Narayana Hrudayalaya Ltd's Q2 FY27

  • Artemis Medicare Services Ltd (Q2 FY27)

    Q2 FY27 consolidated revenue from operations: INR 31,104 Lacs, up 13.2% YoY (Page 39, 40, 20). Key investor presentation takeaways from Artemis Medicare Service

  • Max Healthcare Institute Ltd (Q2 FY27)

    Q2 FY27 Gross Revenue: ₹3,219 Cr, up 20% YoY (Page 4, 17) . Key investor presentation takeaways from Max Healthcare Institute Ltd's Q2 FY27 investor presentatio

Compare:vs Apollo Hospitals Enterprise Ltdvs Manipal Health Enterprises Ltdvs Max Healthcare Institute Ltd